Gadolinium Imaging Agents To Get Safety Review At FDA Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Sponsors are conducting mandatory clinical trials on the risk for patients with moderate to severe renal insufficiency.